News
Philips sees tough European, US healthcare markets – Business Recorder
fp.brecorder.com
Philips forecast a slow first half of the year due to the weak European economy and a tough outlook for healthcare spending in the United States, sending its
Johnson & Johnson gets a shot in the arm with Dutch deal | London...
www.standard.co.uk
But the likelihood of a bidding war is small," said Fabian Smeets, analyst at Rabo Securities. J&J has already finished due diligence on the deal ...
J&J aiming to buy vaccine maker Crucell for $2.3 billion su Mazi blog
blog.libero.it
Rabo Securities analyst Fabian Smeets said Britain's GlaxoSmithKline and Sanofi-Aventis, who have their own vaccine operations, were unlikely to bid as Swiss firm Novartis could then break a partnership in which it supplies ...
DSM seeks more deals after big nutrition push - Reuters
www.reuters.com
But ING analyst Fabian Smeets predicted DSM could still beat the 1.4 billion given more buys in the pipeline.
sorted by relevance / date